Guidelines interpretation of the American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Secondary and Tertiary Renal Hyperparathyroidism_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

ZHOU Li ^1,2 ,  LI Zhihui ^2,3

1. Department of Nephrology, West China Hospital, Sichuan University, Chengdu 610041, P. R. China;
2. The West China MDT of Hyperparathyroidism, West China Hospital, Sichuan University, Chengdu 610041, P. R. China;
3. Department of Thyroid Surgery, West China Hospital, Sichuan University, Chengdu 610041, P. R. China;

Corresponding author：

LI Zhihui, Email: rockoliver@vip.sina.com

Keywords：

the American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Secondary and Tertiary Renal Hyperparathyroidism; interpretation; surgery

DOI：

10.7507/1007-9424.202301038

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Secondary and tertiary hyperparathyroidism are common complications in patients with chronic kidney disease, especially in end stage renal disease. Surgery is an important method for the treatment of secondary and tertiary hyperparathyroidism. The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Secondary and Tertiary Renal Hyperparathyroidism is the first evidence based guideline focus on renal hyperparathyroidism surgical management. Recommendations using the best available evidence by a panel of 10 experts in secondary and tertiary renal hyperparathyroidism constructed this guideline, which provides evidence-based, individual and optimal surgical management of secondary and tertiary renal hyperparathyroidism. This paper made a guideline interpretation on the indications of surgery, imaging examination, preoperative and perioperative management, relevant evaluation and treatment during perioperative period, and intraoperative parathyroid hormone monitoring during operation, and so on.

Citation： ZHOU Li, LI Zhihui. Guidelines interpretation of the American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Secondary and Tertiary Renal Hyperparathyroidism. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2023, 30(2): 160-166. doi: 10.7507/1007-9424.202301038 Copy

1.	Dream S, Kuo LE, Kuo JH, et al. The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Secondary and Tertiary Renal Hyperparathyroidism. Ann Surg, 2022, 276(3): e141-e176.
2.	Levin A, Bakris GL, Molitch M, et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int, 2007, 71(1): 31-38.
3.	Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl, 2017, 7(1): 1-59.
4.	Fuller DS, Dluzniewski PJ, Cooper K, et al. Combinations of mineral and bone disorder markers and risk of death and hospitalizations in the international Dialysis Outcomes and Practice Patterns Study. Clin Kidney J, 2019, 13(6): 1056-1062.
5.	贺青卿, 田文. 慢性肾脏病继发甲状旁腺功能亢进外科临床实践中国专家共识(2021版). 中国实用外科杂志, 2021, 41(8): 841-848.
6.	Burmeister LA, Sandberg M, Carty SE, et al. Thyroid carcinoma found at parathyroidectomy: association with primary, secondary, and tertiary hyperparathyroidism. Cancer, 1997, 79(8): 1611-1616.
7.	Preda C, Branisteanu D, Armasu I, et al. Coexistent papillary thyroid carcinoma diagnosed in surgically treated patients for primary versus secondary hyperparathyroidism: same incidence, different characteristics. BMC Surg, 2019, 19(1): 94. doi: 10.1186/s12893-019-0556-y.
8.	Miki H, Oshimo K, Inoue H, et al. Thyroid carcinoma in patients with secondary hyperparathyroidism. J Surg Oncol, 1992, 49(3): 168-171.
9.	Anderson K Jr, Ruel E, Adam MA, et al. Subtotal vs. total parathyroidectomy with autotransplantation for patients with renal hyperparathyroidism have similar outcomes. Am J Surg, 2017, 214(5): 914-919.
10.	Schneider R, Slater EP, Karakas E, et al. Initial parathyroid surgery in 606 patients with renal hyperparathyroidism. World J Surg, 2012, 36(2): 318-326.
11.	Kuo LE, Wachtel H, Karakousis G, et al. Parathyroidectomy in dialysis patients. J Surg Res, 2014, 190(2): 554-558.
12.	Pitt SC, Panneerselvan R, Chen H, et al. Secondary and tertiary hyperparathyroidism: the utility of ioPTH monitoring. World J Surg, 2010, 34(6): 1343-1349.
13.	Ishani A, Liu J, Wetmore JB, et al. Clinical outcomes after parathyroidectomy in a nationwide cohort of patients on hemodialysis. Clin J Am Soc Nephrol, 2015, 10(1): 90-97.
14.	Lee JD, Kuo EJ, Du L, et al. Risk factors for readmission after parathyroidectomy for renal hyperparathyroidism. World J Surg, 2019, 43(2): 534-539.
15.	Puccini M, Carpi A, Cupisti A, et al. Total parathyroidectomy without autotransplantation for the treatment of secondary hyperparathyroidism associated with chronic kidney disease: clinical and laboratory long-term follow-up. Biomed Pharmacother, 2010, 64(5): 359-362.
16.	Demeure MJ, McGee DC, Wilkes W, et al. Results of surgical treatment for hyperparathyroidism associated with renal disease. Am J Surg, 1990, 160(4): 337-340.
17.	Steffen L, Moffa G, Müller PC, et al. Secondary hyperparathyroidism: recurrence after total parathyroidectomy with autotransplantation. Swiss Med Wkly, 2019, 149: w20160.
18.	Schlosser K, Endres N, Celik I, et al. Surgical treatment of tertiary hyperparathyroidism: the choice of procedure matters! World J Surg, 2007, 31(10): 1947-1953.
19.	Kilgo MS, Pirsch JD, Warner TF, et al. Tertiary hyperparathyroidism after renal transplantation: surgical strategy. Surgery, 1998, 124(4): 677-684.
20.	Triponez F, Dosseh D, Hazzan M, et al. Subtotal parathyroidectomy with thymectomy for autonomous hyperparathyroidism after renal transplantation. Br J Surg, 2005, 92(10): 1282-1287.
21.	Triponez F, Dosseh D, Hazzan M, et al. Accuracy of intra-operative PTH measurement during subtotal parathyroidectomy for tertiary hyperparathyroidism after renal transplantation. Langenbecks Arch Surg, 2006, 391(6): 561-565.
22.	Punch JD, Thompson NW, Merion RM. Subtotal parathyroidectomy in dialysis-dependent and post-renal transplant patients. a 25-year single-center experience. Arch Surg, 1995, 130(5): 538-542.
23.	Isaksson E, Ivarsson K, Akaberi S, et al. Total versus subtotal parathyroidectomy for secondary hyperparathyroidism. Surgery, 2019, 165(1): 142-150.
24.	Rajeev P, Lee KY, Tang XJ, et al. Outcomes of parathyroidectomy in renal hyperparathyroidism in patients with no access to renal transplantation in Singapore. Int J Surg, 2016, 25: 64-68.
25.	Conzo G, Perna AF, Sinisi AA, et al. Total parathyroidectomy without autotransplantation in the surgical treatment of secondary hyperparathyroidism of chronic kidney disease. J Endocrinol Invest, 2012, 35(1): 8-13.
26.	Agha A, Loss M, Schlitt HJ, et al. Recurrence of secondary hyperparathyroidism in patients after total parathyroidectomy with autotransplantation: technical and therapeutic aspects. Eur Arch Otorhinolaryngol, 2012, 269(5): 1519-1525.

1. Dream S, Kuo LE, Kuo JH, et al. The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Secondary and Tertiary Renal Hyperparathyroidism. Ann Surg, 2022, 276(3): e141-e176.
2. Levin A, Bakris GL, Molitch M, et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int, 2007, 71(1): 31-38.
3. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl, 2017, 7(1): 1-59.
4. Fuller DS, Dluzniewski PJ, Cooper K, et al. Combinations of mineral and bone disorder markers and risk of death and hospitalizations in the international Dialysis Outcomes and Practice Patterns Study. Clin Kidney J, 2019, 13(6): 1056-1062.
5. 贺青卿, 田文. 慢性肾脏病继发甲状旁腺功能亢进外科临床实践中国专家共识(2021版). 中国实用外科杂志, 2021, 41(8): 841-848.
6. Burmeister LA, Sandberg M, Carty SE, et al. Thyroid carcinoma found at parathyroidectomy: association with primary, secondary, and tertiary hyperparathyroidism. Cancer, 1997, 79(8): 1611-1616.
7. Preda C, Branisteanu D, Armasu I, et al. Coexistent papillary thyroid carcinoma diagnosed in surgically treated patients for primary versus secondary hyperparathyroidism: same incidence, different characteristics. BMC Surg, 2019, 19(1): 94. doi: 10.1186/s12893-019-0556-y.
8. Miki H, Oshimo K, Inoue H, et al. Thyroid carcinoma in patients with secondary hyperparathyroidism. J Surg Oncol, 1992, 49(3): 168-171.
9. Anderson K Jr, Ruel E, Adam MA, et al. Subtotal vs. total parathyroidectomy with autotransplantation for patients with renal hyperparathyroidism have similar outcomes. Am J Surg, 2017, 214(5): 914-919.
10. Schneider R, Slater EP, Karakas E, et al. Initial parathyroid surgery in 606 patients with renal hyperparathyroidism. World J Surg, 2012, 36(2): 318-326.
11. Kuo LE, Wachtel H, Karakousis G, et al. Parathyroidectomy in dialysis patients. J Surg Res, 2014, 190(2): 554-558.
12. Pitt SC, Panneerselvan R, Chen H, et al. Secondary and tertiary hyperparathyroidism: the utility of ioPTH monitoring. World J Surg, 2010, 34(6): 1343-1349.
13. Ishani A, Liu J, Wetmore JB, et al. Clinical outcomes after parathyroidectomy in a nationwide cohort of patients on hemodialysis. Clin J Am Soc Nephrol, 2015, 10(1): 90-97.
14. Lee JD, Kuo EJ, Du L, et al. Risk factors for readmission after parathyroidectomy for renal hyperparathyroidism. World J Surg, 2019, 43(2): 534-539.
15. Puccini M, Carpi A, Cupisti A, et al. Total parathyroidectomy without autotransplantation for the treatment of secondary hyperparathyroidism associated with chronic kidney disease: clinical and laboratory long-term follow-up. Biomed Pharmacother, 2010, 64(5): 359-362.
16. Demeure MJ, McGee DC, Wilkes W, et al. Results of surgical treatment for hyperparathyroidism associated with renal disease. Am J Surg, 1990, 160(4): 337-340.
17. Steffen L, Moffa G, Müller PC, et al. Secondary hyperparathyroidism: recurrence after total parathyroidectomy with autotransplantation. Swiss Med Wkly, 2019, 149: w20160.
18. Schlosser K, Endres N, Celik I, et al. Surgical treatment of tertiary hyperparathyroidism: the choice of procedure matters! World J Surg, 2007, 31(10): 1947-1953.
19. Kilgo MS, Pirsch JD, Warner TF, et al. Tertiary hyperparathyroidism after renal transplantation: surgical strategy. Surgery, 1998, 124(4): 677-684.
20. Triponez F, Dosseh D, Hazzan M, et al. Subtotal parathyroidectomy with thymectomy for autonomous hyperparathyroidism after renal transplantation. Br J Surg, 2005, 92(10): 1282-1287.
21. Triponez F, Dosseh D, Hazzan M, et al. Accuracy of intra-operative PTH measurement during subtotal parathyroidectomy for tertiary hyperparathyroidism after renal transplantation. Langenbecks Arch Surg, 2006, 391(6): 561-565.
22. Punch JD, Thompson NW, Merion RM. Subtotal parathyroidectomy in dialysis-dependent and post-renal transplant patients. a 25-year single-center experience. Arch Surg, 1995, 130(5): 538-542.
23. Isaksson E, Ivarsson K, Akaberi S, et al. Total versus subtotal parathyroidectomy for secondary hyperparathyroidism. Surgery, 2019, 165(1): 142-150.
24. Rajeev P, Lee KY, Tang XJ, et al. Outcomes of parathyroidectomy in renal hyperparathyroidism in patients with no access to renal transplantation in Singapore. Int J Surg, 2016, 25: 64-68.
25. Conzo G, Perna AF, Sinisi AA, et al. Total parathyroidectomy without autotransplantation in the surgical treatment of secondary hyperparathyroidism of chronic kidney disease. J Endocrinol Invest, 2012, 35(1): 8-13.
26. Agha A, Loss M, Schlitt HJ, et al. Recurrence of secondary hyperparathyroidism in patients after total parathyroidectomy with autotransplantation: technical and therapeutic aspects. Eur Arch Otorhinolaryngol, 2012, 269(5): 1519-1525.

Previous Article
Proposal for risk control of thoracic surgery during the COVID-19 pandemic
Next Article
Cardiovascular surgery in COVID-19: Change and countermeasure

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Guidelines interpretation of the American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Secondary and Tertiary Renal Hyperparathyroidism

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content